A 36-week treatment regimen of pegcetacoplan reduces geographic atrophy growth rate while demonstrating a favorable safety profile.

Perspectives of patients with spinal muscular atrophy (SMA) and their caregivers should be weighed before making decisions around SMA-enhancing treatments.

A rare spinal surgery in Thiruvananthapuram, India, has transformed the life of 23-year-old Mohamad Raishan Ahmed from the ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and ...

A research team at the University of California has uncovered a link between sleep quality in midlife and brain atrophy, a ...

Now, researchers from University of California San Diego and their colleagues report that they have identified a key pathway ...

A 57-year-old man suffering from debilitating pain, numbness, and difficulty walking found relief through immunotherapy, ...

Williams appears gaunt, which experts say might indicate nutritional deficiencies A photo of a NASA astronaut putting ...

The spinal defect of a 23-year-old Maldivian was cured through a rare surgery at a private hospital in Thiruvananthapuram that has fulfilled his prolonged wish ...

Subsequent to quarter-end, closed $30 million in debt financingOCU400 Phase 3 liMeliGhT clinical trial for retinitis pigmentosa (RP) on track to ...

The temporal muscles, essential for chewing and jaw movements, may atrophy or weaken due to factors like disuse or aging.

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers of multiple sclerosis progression.